glyburide and oxyntomodulin

glyburide has been researched along with oxyntomodulin in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	6 (85.71)	18.2507
2000's	1 (14.29)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Habener, JF; Holz, GG; Kühtreiber, WM	1
Atillasoy, EJ; Burtis, WJ; Gaich, G; Ganz, MB; Orloff, JJ; Stewart, AF	1
Andrews, KM; Hargrove, DM; Nardone, NA; Parker, JC; Persson, LM; Shepherd, KL; Stevenson, RW	1
Efendic, S; Guenifi, A; Gutniak, MK; Hellström, PM; Holst, JJ; Juntti-Berggren, L	1
Komatsu, M; Noda, M; Sharp, GW	1
Bataille, D; Blache, P; Dalle, S; Le Brigand, L; Le-Nguyen, D	1
Briaud, I; Dickson, LM; Lingohr, MK; Rhodes, CJ; Wrede, CE	1

Trials

1 trial(s) available for glyburide and oxyntomodulin

Article	Year
Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas. Diabetes care, 1996, Volume: 19, Issue:8 Topics: Analysis of Variance; Animals; Diabetes Mellitus, Type 2; Drug Synergism; Drug Therapy, Combination; Gastric Emptying; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glyburide; Humans; In Vitro Techniques; Infusions, Intravenous; Insulin; Insulin Secretion; Islets of Langerhans; Middle Aged; Peptide Fragments; Perfusion; Protein Precursors; Rats; Rats, Sprague-Dawley; Treatment Failure	1996

Article

Year

Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas.

Diabetes care, 1996, Volume: 19, Issue:8

Topics: Analysis of Variance; Animals; Diabetes Mellitus, Type 2; Drug Synergism; Drug Therapy, Combination; Gastric Emptying; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glyburide; Humans; In Vitro Techniques; Infusions, Intravenous; Insulin; Insulin Secretion; Islets of Langerhans; Middle Aged; Peptide Fragments; Perfusion; Protein Precursors; Rats; Rats, Sprague-Dawley; Treatment Failure

1996

Other Studies

6 other study(ies) available for glyburide and oxyntomodulin

Article	Year
Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37). Nature, 1993, Jan-28, Volume: 361, Issue:6410 Topics: Animals; Cells, Cultured; Cyclic AMP; Drug Synergism; Electric Conductivity; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose; Glyburide; Islets of Langerhans; Male; Membrane Potentials; Peptide Fragments; Peptides; Rats; Thionucleotides	1993
Amino-terminal parathyroid hormone-related protein: specific binding and cytosolic calcium responses in rat insulinoma cells. Endocrinology, 1993, Volume: 132, Issue:3 Topics: Animals; Binding Sites; Calcium; Cell Membrane; Cyclic AMP; Cytosol; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glyburide; Insulinoma; Kinetics; Pancreatic Neoplasms; Parathyroid Hormone; Parathyroid Hormone-Related Protein; Peptide Fragments; Peptides; Proteins; Rats; Rats, Inbred WF; Tumor Cells, Cultured	1993
Comparison of the glucose dependency of glucagon-like peptide-1 (7-37) and glyburide in vitro and in vivo. Metabolism: clinical and experimental, 1996, Volume: 45, Issue:3 Topics: Animals; Fasting; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose; Glyburide; Hypoglycemic Agents; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Male; Peptide Fragments; Peptides; Rats; Rats, Sprague-Dawley	1996
The betaHC-9 pancreatic beta-cell line preserves the characteristics of progenitor mouse islets. Diabetes, 1996, Volume: 45, Issue:12 Topics: Animals; Arginine; Calcium; Carbachol; Cell Division; Cell Line; Glucagon-Like Peptides; Glucose; Glyburide; Insulin; Insulin Secretion; Islets of Langerhans; Leucine; Male; Mice; Neuropeptides; Peptides; Pituitary Adenylate Cyclase-Activating Polypeptide; Rats; Rats, Sprague-Dawley	1996
Miniglucagon: a local regulator of islet physiology. Annals of the New York Academy of Sciences, 1998, Dec-11, Volume: 865 Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channels; Calcium Channels, L-Type; Cell Line; Cell Membrane; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose; Glyburide; Homeostasis; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Membrane Potentials; Peptide Fragments; Peptides	1998
Differential activation mechanisms of Erk-1/2 and p70(S6K) by glucose in pancreatic beta-cells. Diabetes, 2003, Volume: 52, Issue:4 Topics: Animals; Calcium; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Enzyme Activation; Enzyme Inhibitors; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptides; Glucose; Glyburide; Humans; Islets of Langerhans; Isoquinolines; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Peptide Fragments; Phosphorylation; Proto-Oncogene Proteins c-raf; Rats; Rats, Sprague-Dawley; Ribosomal Protein S6 Kinases, 70-kDa; Sulfonamides; Verapamil	2003